Cite
HARVARD Citation
McDowell, P. et al. (2021). The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study. Lancet. 9 (10), pp. 1174-1184. [Online].